There has been a halt in the late-stage trial of AstraZeneca's oral prostate cancer drug zibotentan. This has happened because it was unsuccessful in meeting its primary endpoints.

The way the shareholders of French drugmaker, Sanofi Aventis, have shown their dissent towards its bid for US biotech firm, Genzyme; there is no doubt that it is presently in a very critical situation

AstraZeneca, Britain’s second largest drug-manufacturers’s shares have advanced 41p to £29.63½, following its announcement of responding to US Food and Drug Administration’s questions about its new bl

It has been found by the FDA that some patients who have taken Sanofi-Aventis' (SNY) Multaq heart disease drug have suffered from some or the other kind of liver disease.

On Monday, pharmaceutical company Abbott Laboratories said that its exp

Roche Holding AG (ROG. VX), the largest oncology drugs producer in the world, is risking a loss of over a billion Swiss francs ($1 billion) in sales next year in case the U. S. and EU regulators make up their minds to revoke top-selling Avastin's license for treating people suffering from breast cancer.

Amid stocks are decreasing through which European sovereign-debt hace a continuous fear. Moreover Spain and Portugal are alleging repeatedly that they do not want the bailout. It is predicted that there will be a good holiday in the U. S.

Abbott Laboratories has pulled diet drug Meridia off United States pharmacies after FDA issued warning against the drug.